MenuPost an ad
Date from 28/09/2021
Date to 29/09/2021

While some developers are implementing lessons learned - and launching - their 2nd C and GTs to market, the majority are hoping the launch strategy for their 1st holds strong, as they navigate through a meteor shower of risky unknowns, firsts, new partnerships, and complexities the average pharma team has never experienced before.

To succeed commercially, pharma and biotech need to formulate a launch strategy that engages the right commercial resource early on, rewrites traditional payment models in partnership with payers, and provides an integrated delivery network that scales up seamlessly, end-to-end.

At Reuters Events' Cell and Gene Therapy USA 2021, you will receive key lessons learned from those who have already achieved lift-off. C-suite, commercial strategy, manufacturing and supply, pricing and access experts will provide you with the tools to launch successfully and sustain and scale your cell and gene therapy delivery in to hyperdrive.

Time: 09:00 to 17:00

Venue details: Online

Beware of scammers by reading our top tips on
how to avoid a scam

Contact the advertiser

Don't forget to mention Vivastreet when you get in touch!

Anything wrong with this ad?

Let us know what the problem is, we will review it accordingly.

Send a message


Address: London, UK SW9 8RR

Photos for Unleash Your Inner Creativity

Coldharbour Lane - SW9

Photos for Coaching and Mentoring Course - 18th April 2022

Islington - N1

Photos for Brent | Wembley and Harrow Fireworks Display

Harrow - HA3

Photos for Ethical Matters: How to Stop Fascism with Paul Mason

High Holborn - WC1

CLF Art Laughter Lou

Rye Lane - SE15

Photos for Lorraine Hansberry: Sighted EyesFeeling Hearts + Q&A

South Norwood - SE25

See all ads ( 234 ads ) Member since: 31/01/2013

Didn't find what you were looking for?

< Back to results

Contact the advertiser

Don't forget to mention Vivastreet when you get in touch!

Vivastreet Safety Centre

  • Your safety is of paramount importance to us.
Tell us what you think